How many drugs treat At risk of osteoporotic fracture?

Drug Landscape tracks 1 marketed treatments for At risk of osteoporotic fracture (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/at-risk-of-osteoporotic-fracture.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

At risk of osteoporotic fracture — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

At risk of osteoporotic fracture (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating At risk of osteoporotic fracture, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Tymlos	ABALOPARATIDE	Radius	Parathyroid Hormone-Related Peptide Analog [EPC]	Parathyroid hormone/parathyroid hormone-related peptide receptor		2017-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Radius · 1 drug in At risk of osteoporotic fracture

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in At risk of osteoporotic fracture:

Cite this brief

Drug Landscape (2026). At risk of osteoporotic fracture — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/at-risk-of-osteoporotic-fracture. Accessed 2026-06-11.

At risk of osteoporotic fracture full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing